Literature DB >> 14605258

Rhinovirus 16 3C protease induces interleukin-8 and granulocyte-macrophage colony-stimulating factor expression in human bronchial epithelial cells.

Ann W Funkhouser1, Jeong-Ah Kang, Alan Tan, Jing Li, Limei Zhou, Mark K Abe, Julian Solway, Marc B Hershenson.   

Abstract

Rhinovirus (RV), a member of the Picornaviridae family, accounts for many virus-induced asthma exacerbations. RV induces airway cell chemokine expression both in vivo and in vitro. Because of the known interactions of proteases with cellular functions, we hypothesized that RV 3C protease is sufficient for cytokine up-regulation. A cDNA encoding RV16 3C protease was constructed by PCR amplification and transfected into 16HBE14o- human bronchial epithelial cells. 3C protease induced expression of both IL-8 and GM-CSF, as well as transcription from both the IL-8 and GM-CSF promoters. 3C expression also induced activator protein 1 and NF-kappaB transcriptional activation. Finally, mutation of IL-8 promoter AP-1 and NF-kappaB promoter sequences significantly reduced 3C-induced responses. Together, these data suggest expression of RV16 3C protease is sufficient to induce chemokine expression in human bronchial epithelial cells, and does so in an AP-1- and NF-kappaB-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605258     DOI: 10.1203/01.PDR.0000099801.06360.AB

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

1.  Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.

Authors:  Vasile Laza-Stanca; Luminita A Stanciu; Simon D Message; Michael R Edwards; James E Gern; Sebastian L Johnston
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes.

Authors:  Kelly Watters; Ann C Palmenberg
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus.

Authors:  Nathan W Bartlett; Louise Slater; Nicholas Glanville; Jennifer J Haas; Gaetano Caramori; Paolo Casolari; Deborah L Clarke; Simon D Message; Julia Aniscenko; Tatiana Kebadze; Jie Zhu; Patrick Mallia; Joseph P Mizgerd; Maria Belvisi; Alberto Papi; Sergei V Kotenko; Sebastian L Johnston; Michael R Edwards
Journal:  EMBO Mol Med       Date:  2012-11-14       Impact factor: 12.137

Review 4.  Rhinoviruses, allergic inflammation, and asthma.

Authors:  Monica L Gavala; Paul J Bertics; James E Gern
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

5.  Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+ ATPase G1 subunit.

Authors:  Cheng-Wen Lin; Fuu-Jen Tsai; Lei Wan; Chien-Chen Lai; Kuan-Hsun Lin; Tsung-Han Hsieh; Shi-Yi Shiu; Jeng-Yi Li
Journal:  FEBS Lett       Date:  2005-10-06       Impact factor: 4.124

6.  Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis.

Authors:  Cheng-Wen Lin; Kuan-Hsun Lin; Tsung-Han Hsieh; Shi-Yi Shiu; Jeng-Yi Li
Journal:  FEMS Immunol Med Microbiol       Date:  2006-04

Review 7.  New treatment regimes for virus-induced exacerbations of asthma.

Authors:  Michael R Edwards; Tatiana Kebadze; Malcolm W Johnson; Sebastian L Johnston
Journal:  Pulm Pharmacol Ther       Date:  2005-11-10       Impact factor: 3.410

Review 8.  Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document.

Authors:  N G Papadopoulos; P Xepapadaki; P Mallia; G Brusselle; J-B Watelet; M Xatzipsalti; G Foteinos; C M van Drunen; W J Fokkens; C D'Ambrosio; S Bonini; A Bossios; Jan Lötvall; P van Cauwenberge; S T Holgate; G W Canonica; A Szczeklik; G Rohde; J Kimpen; A Pitkäranta; M Mäkelä; P Chanez; J Ring; S L Johnston
Journal:  Allergy       Date:  2007-02-27       Impact factor: 13.146

Review 9.  The role of viruses in acute exacerbations of asthma.

Authors:  David J Jackson; Sebastian L Johnston
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

Review 10.  Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.

Authors:  Michael R Edwards; Nathan W Bartlett; Deborah Clarke; Mark Birrell; Maria Belvisi; Sebastian L Johnston
Journal:  Pharmacol Ther       Date:  2008-10-06       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.